Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0030567 (
Parkinson's disease
)
63,064
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Mutations in the PARK7 gene
DJ-1
are associated with recessive hereditary
Parkinson's disease
(PD). Fibrillar inclusions of alpha-synuclein comprise the neuropathological hallmarks of PD and related Lewy body diseases as well as multiple system atrophy (MSA). Moreover, neuronal and glial inclusions containing tau have been observed in alpha-synucleinopathy patients. Using a collection of antibodies against
DJ-1
, we have performed a comprehensive investigation of
DJ-1
in alpha-synucleinopathies and tauopathies.
DJ-1
was abundantly expressed in reactive astrocytes of patients with neurodegenerative diseases. Likewise,
DJ-1
antiserum immunostained reactive astrocytes that became abundant with disease progression in the brain stem of transgenic mice expressing mutant [A30P]alpha-synuclein. Human Lewy bodies as well as Lewy body-like inclusions in the alpha-synuclein transgenic mice were
DJ-1
negative. Neuronal tau inclusions were
DJ-1
immunopositive in Pick's disease (PiD), corticobasal degeneration (CBD), progressive supranuclear palsy (PSP), and Alzheimer's disease. In addition, we found
DJ-1
-immunopositive glial inclusions in CBD, PSP and MSA. Biochemical extraction experiments revealed the specific presence of insoluble, modified
DJ-1
in PiD and MSA. Our results suggest that
DJ-1
is up-regulated in reactive astrocytes as well as in neuronal and glial cells with specific alpha-synucleinopathy and tauopathy.
...
PMID:Pathological properties of the Parkinson's disease-associated protein DJ-1 in alpha-synucleinopathies and tauopathies: relevance for multiple system atrophy and Pick's disease. 1499 85
Mutation in
DJ-1
gene is the cause of autosomal recessive
Parkinson's disease
, however, its physiological function remains unclear. The isoelectric point of
DJ-1
shows an acidic shift after cells are treated with hydrogen peroxide. This suggests that
DJ-1
is modified in response to oxidative stress. Here we report the structural characterization of an acidic isoform of
DJ-1
using a proteomic approach with nanospray interface liquid chromatography-electrospray ionization/linear ion trap mass spectrometer. When human umbilical vein endothelial cells were exposed to hydrogen peroxide, all three cysteines in
DJ-1
were oxidized to cysteine sulphonic acid. Although a small part of the Cys-46 and Cys-53 were oxidized, Cys-106 was oxidized completely at any hydrogen peroxide concentration used here. These results suggest that Cys-106 is the most sensitive among three cysteine residues to oxidative stress, and that
DJ-1
function is regulated, in terms of the intracellular redox state, by oxidation of Cys-106.
...
PMID:Cysteine-106 of DJ-1 is the most sensitive cysteine residue to hydrogen peroxide-mediated oxidation in vivo in human umbilical vein endothelial cells. 1508
Loss-of-function
DJ-1
mutations can cause early-onset
Parkinson's disease
. The function of
DJ-1
is unknown, but an acidic isoform accumulates after oxidative stress, leading to the suggestion that
DJ-1
is protective under these conditions. We addressed whether this represents a posttranslational modification at cysteine residues by systematically mutating cysteine residues in human
DJ-1
. WT or C53A
DJ-1
was readily oxidized in cultured cells, generating a pI 5.8 isoform, but an artificial C106A mutant was not. We observed a cysteine-sulfinic acid at C106 in crystalline
DJ-1
but no modification of C53 or C46. Oxidation of
DJ-1
was promoted by the crystallization procedure. In addition, oxidation-induced mitochondrial relocalization of
DJ-1
and protection against cell death were abrogated in C106A but not C53A or C46A. We suggest that
DJ-1
protects against neuronal death, and that this is signaled by acidification of the key cysteine residue, C106.
...
PMID:The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. 1518 Dec
Parkinson's disease
(PD) is thought to be caused by environmental and genetic factors. Mutations in four genes, alpha-synuclein, parkin,
DJ-1
, and UCH-L1, have been identified in autosomal inherited forms of PD. The pathogenetic cause for the loss of neuronal cells in PD patients, however, remains to be determined. Due to the rarity of mutations in humans with PD, the analysis of animal models might help to further gain insights into the pathogenesis of familial PD. For UCH-L1, deficiency has been described in gad mice leading to axonal degeneration and formation of spheroid bodies in nerve terminals. Here, we investigated the gene expression pattern of the brain of 3-month-old Uch-l1-deficient gracile axonal dystrophy (gad) mice by microarray analysis. A total of 146 genes were differentially regulated by at least a 1.4-fold change with 103 being up-regulated and 43 being down-regulated compared with age and sex matched wildtype littermate mice. The gene products with altered expression are involved in protein degradation, cell cycle, vesicle transport, cellular structure, signal transduction, and transcription regulation. Most of the genes were modestly regulated, which is in agreement that severe alteration of these pathways might be lethal. Among the genes most significantly down-regulated is the brain-derived neurotrophic factor which might be one aspect of the pathogenesis in gad mice. Interestingly, several subunits of the transcription factor CCAAT/enhancer binding protein are up-regulated, which plays a central role in most altered pathways.
...
PMID:Microarray expression analysis of gad mice implicates involvement of Parkinson's disease associated UCH-L1 in multiple metabolic pathways. 1520 21
DJ-1
is a multi-functional protein that plays roles in transcriptional regulation and anti-oxidative stress, and loss of its function is thought to result in onset of
Parkinson's disease
. We have previously reported that L166P, a mutant
DJ-1
found in
Parkinson's disease
patients, had no activity to prevent hydrogen peroxide (H2O2)-induced cell death. In this study, we analyzed other mutants of
DJ-1
found in
Parkinson's disease
patients, including M26I, R98Q, and D149A, as well as L166P. We first found that all of the mutants made heterodimers with wild-type
DJ-1
, while all of the mutants except for L166P made homodimers. We then found that M26I and L166P, both of which are derived from homozygous mutations of the
DJ-1
gene, were unstable and that their stabilities were recovered, in part, in the presence of proteasome inhibitor, MG132. NIH3T3 cell lines stably expressing these mutants of
DJ-1
showed that cell lines of L166P and C106S, a mutant for protease activity (-) of
DJ-1
, had no activity to scavenge even endogenously producing reactive oxygen species. These cell lines also showed that all of the mutants had reduced activities to eliminate exogenously added H2O2 and that these activities, except for that of D149A, were parallel to those preventing H2O2-induced cell death.
...
PMID:Reduced anti-oxidative stress activities of DJ-1 mutants found in Parkinson's disease patients. 1521 40
The frequency and relative contribution of
DJ-1
mutations in early-onset
Parkinson's disease
(EOPD) is currently unknown. We analyzed a cohort of 89 EOPD patients (mean age at onset of PD +/- SD, 41.5 +/- 7.2 years), ascertained independent of family history, who participated in a study of the genetic epidemiology of PD. This study includes sequence analysis of the
DJ-1
gene in addition to assaying the 14,082-bp deletion spanning exons 1 to 5, previously identified in a Dutch kindred, in 89 EOPD cases. A heterozygous missense mutation in exon 5 (A104T) was identified in an EOPD case of Asian ethnicity; this sequence variant was absent in 308 control chromosomes. We identified additional sequence variation in the
DJ-1
gene, including a polymorphism in the coding region in exon 5 (R98Q), three polymorphisms in the 5' untranslated region (exon 1A/1B), and two polymorphisms in intronic regions (IVS1 and IVS5). Mutations in the
DJ-1
gene are rare in EOPD in both sporadic and familial cases.
...
PMID:Analysis of an early-onset Parkinson's disease cohort for DJ-1 mutations. 1525 37
DJ-1
is a conserved protein reported to be involved in diverse cellular processes ranging from cellular transformation, control of protein-RNA interaction, oxidative stress response to control of male infertility, among several others. Mutations in the human gene have been shown to be associated with an autosomal recessive, early onset
Parkinson's disease
(PARK7). The present study examines the control of
DJ-1
expression in prostatic benign hyperplasia (BPH-1) and cancer (PC-3) cell lines in which
DJ-1
abundance differs significantly. We show that while BPH-1 cells exhibit low basal level of
DJ-1
expression, stress-inducing agents such as H(2)O(2) and mitomycin C markedly increase the intracellular level of the polypeptide. In contrast,
DJ-1
expression is relatively high in PC-3 cells, and incubation with the same cytotoxic drugs does not modulate further the level of the polypeptide. In correlation with the expression of
DJ-1
, both cytotoxic agents activate the apoptotic pathway in the prostatic benign cells but not in PC-3 cells, which are resistant to their action. We further demonstrate that incubation of BPH-1 cells with TNF-related-apoptosis-inducing-ligand/Apo-2L (TRAIL) also enhances
DJ-1
expression and that TRAIL and H(2)O(2) act additively to stimulate
DJ-1
accumulation but synergistically in the activation of the apoptotic pathway. Time-course analysis of
DJ-1
stimulation shows that while
DJ-1
level increases without significant lag in TRAIL-treated cells, there is a delay in H(2)O(2)-treated cells, and that the increase in
DJ-1
abundance precedes the activation of apoptosis. Unexpectedly, over-expression of
DJ-1
de-sensitizes BPH-1 cells to the action of apoptotic-inducing agents. However, RNA-interference-mediated silencing of
DJ-1
expression results in sensitization of PC-3 cells to TRAIL action. These results are consistent with a model in which
DJ-1
is involved in the control of cell death in prostate cell lines.
DJ-1
appears to play a differential role between cells expressing a low but inducible level of
DJ-1
(e.g., BPH-1 cells) and those expressing a high but constitutive level of the polypeptide (e.g., PC-3 cells).
...
PMID:Differential control of apoptosis by DJ-1 in prostate benign and cancer cells. 1525 5
Recessively inherited mutations in parkin,
DJ-1
, and PINK1 have recently been linked to familial forms of parkinsonism. These syndromes are often clinically indistinguishable from
Parkinson's disease
, as similar neuronal groups, notably dopaminergic neurons, are selectively affected. Studies of the functions of these gene products may provide insights into the pathogenic mechanisms underlying the selective degeneration of dopaminergic neurons. Emerging evidence that one or several of these genes play important roles in mitochondrial function and the dopaminergic system suggests that these events may be early steps of the pathophysiological changes of the disease. This review will summarize recent advances in our understanding of these gene products, with emphasis on the surprising convergence of their functions.
...
PMID:Mitochondria and dopamine: new insights into recessive parkinsonism. 1529 38
Two genes were identified for autosomal recessive forms of early onset
Parkinson's disease
: parkin and
DJ-1
. We describe 2 siblings with EOPD due to parkin mutations and peripheral neuropathy, which presented as neuropathy with liability to pressure palsies (HNPP) in the index case. RT-PCR experiments revealed that the parkin gene is expressed in sural nerves from both controls and patient with parkin-related disease. Our findings support the view that parkin may play a role in the peripheral nervous system.
...
PMID:Does parkin play a role in the peripheral nervous system? A family report. 1530 Jun 70
Genetic contribution to the etiology of
Parkinson's disease
(PD) is generally accepted based on the studies of the familial form of the disease and progress in molecular genetic techniques. To date, specific mutations have been identified in five separate genes and several chromosomal loci have been linked for different forms of familial parkinsonism. The discovery of alpha-synuclein, ubiquitin C-terminal hydrolase, parkin, tau and
DJ-1
mutations and analysis of the biochemical and molecular properties of these gene products point to the critical role of protein aggregation in dopaminergic neurons of the substantia nigra as the basic mechanism leading to neurodegeneration also in sporadic form of the disease. Lewy bodies, even in sporadic PD, contain some of these gene products, particularly abundant fibrillar alpha-synuclein. Studies of familial parkinsonism provide evidence that PD is genetically heterogeneous. Evidence elucidated from genetic studies in PD suggests that parkinsonism is a complex disorder in which multiple gene-gene and gene-environment interactions play a critical role in the development of the disease and phenotypic variability. Further genetic studies in familial parkinsonism will enhance our knowledge of pathogenesis of PD and allow the development of neuroprotective treatments of PD and perhaps other forms of parkinsonism as well.
...
PMID:[Advances in the genetic studies in Parkinson's disease]. 1530 6
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>